A fast detection of fusion genes from paired-end RNA-seq data
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Trung Nghia Vu | - |
dc.contributor.author | Deng, Wenjiang | - |
dc.contributor.author | Quang Thinh Trac | - |
dc.contributor.author | Calza, Stefano | - |
dc.contributor.author | Hwang, Woochang | - |
dc.contributor.author | Pawitan, Yudi | - |
dc.date.accessioned | 2023-09-18T07:01:36Z | - |
dc.date.available | 2023-09-18T07:01:36Z | - |
dc.date.created | 2023-07-07 | - |
dc.date.issued | 2018-11 | - |
dc.identifier.issn | 1471-2164 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/190843 | - |
dc.description.abstract | BackgroundFusion genes are known to be drivers of many common cancers, so they are potential markers for diagnosis, prognosis or therapy response. The advent of paired-end RNA sequencing enhances our ability to discover fusion genes. While there are available methods, routine analyses of large number of samples are still limited due to high computational demands.ResultsWe develop FuSeq, a fast and accurate method to discover fusion genes based on quasi-mapping to quickly map the reads, extract initial candidates from split reads and fusion equivalence classes of mapped reads, and finally apply multiple filters and statistical tests to get the final candidates. We apply FuSeq to four validated datasets: breast cancer, melanoma and glioma datasets, and one spike-in dataset. The results reveal high sensitivity and specificity in all datasets, and compare well against other methods such as FusionMap, TRUP, TopHat-Fusion, SOAPfuse and JAFFA. In terms of computational time, FuSeq is two-fold faster than FusionMap and orders of magnitude faster than the other methods.ConclusionsWith this advantage of less computational demands, FuSeq makes it practical to investigate fusion genes in large numbers of samples. FuSeq is implemented in C++ and R, and available at https://github.com/nghiavtr/FuSeqfor non-commercial uses. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BMC | - |
dc.title | A fast detection of fusion genes from paired-end RNA-seq data | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hwang, Woochang | - |
dc.identifier.doi | 10.1186/s12864-018-5156-1 | - |
dc.identifier.scopusid | 2-s2.0-85055784890 | - |
dc.identifier.wosid | 000448952000002 | - |
dc.identifier.bibliographicCitation | BMC GENOMICS, v.19, no.1, pp.1 - 13 | - |
dc.relation.isPartOf | BMC GENOMICS | - |
dc.citation.title | BMC GENOMICS | - |
dc.citation.volume | 19 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 13 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Genetics & Heredity | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Genetics & Heredity | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | TRANSCRIPTS | - |
dc.subject.keywordPlus | READS | - |
dc.subject.keywordAuthor | Fusion gene | - |
dc.subject.keywordAuthor | RNA sequencing | - |
dc.subject.keywordAuthor | Quasi-mapping | - |
dc.subject.keywordAuthor | Fusion equivalence class | - |
dc.identifier.url | https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-018-5156-1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.